Eden Research (LON:EDEN) Stock Falls 9.1% – Should You Sell?

Eden Research plc (LON:EDEN)’s stock price was down 9.1% during mid-day trading on Tuesday. The stock traded as low as GBX 3.34 and last traded at GBX 3.50. Approximately 6,988,454 shares changed hands during mid-day trading, an increase of 1,038% from the average daily volume of 614,134 shares. The stock had previously closed at GBX 3.85.

Eden Research Stock Down 9.1%

The company has a quick ratio of 2.42, a current ratio of 1.95 and a debt-to-equity ratio of 5.41. The business has a fifty day simple moving average of GBX 2.37 and a two-hundred day simple moving average of GBX 3.04. The company has a market capitalization of £28.12 million, a price-to-earnings ratio of -7.90 and a beta of 1.55.

Eden Research (LON:EDEN) last announced its quarterly earnings results on Wednesday, August 26th. The company reported GBX (0.36) EPS for the quarter. Eden Research had a negative net margin of 50.43% and a negative return on equity of 16.16%. Equities analysts expect that Eden Research plc will post -66.00 EPS for the current year.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.